158 related articles for article (PubMed ID: 38483602)
1. Percutaneous Image-Guided Cryoablation of Endophytic Renal Cell Carcinoma.
Jensen CG; Dybdahl M; Valtersson J; Mussmann BR; Duus LA; Junker T; Pietersen PI; Lund L; Welch BT; Graumann O
Cardiovasc Intervent Radiol; 2024 Apr; 47(4):453-461. PubMed ID: 38483602
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal Masses.
Murray CA; Welch BT; Schmit GD; Schmitz JJ; Weisbrod AJ; Callstrom MR; Welch TL; Thompson RH; Kurup AN; Boorjian SA; Atwell TD
Urology; 2019 Nov; 133():151-156. PubMed ID: 31415781
[TBL] [Abstract][Full Text] [Related]
3. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
[No Abstract] [Full Text] [Related]
7. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer.
Duus LA; Junker T; Rasmussen BS; Bojsen JA; Pedersen AL; Anthonsen A; Lund L; Pedersen M; Graumann O
Acta Radiol; 2023 Feb; 64(2):814-820. PubMed ID: 35297745
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous image-guided cryoablation with temporary balloon occlusion of the renal artery for the treatment of central renal tumors.
Autrusseau PA; Boatta E; Cazzato RL; Auloge P; Mayer T; Weiss J; Koch G; Caudrelier J; De Marini P; Gangi A; Garnon J
Diagn Interv Imaging; 2022 Nov; 103(11):510-515. PubMed ID: 35934617
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes.
Kim DK; Won JY; Park SY
Acta Radiol; 2019 Jun; 60(6):798-804. PubMed ID: 30149751
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
[TBL] [Abstract][Full Text] [Related]
15. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of cryoablation for biopsy-proven T1 stage renal cell carcinoma.
Song S; Yang Q; Gu C; Yu G; Hua B; Gu X; Wang L; Wang Z; Shi G; Xu B
World J Surg Oncol; 2022 Sep; 20(1):284. PubMed ID: 36064369
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
18. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.
Nielsen TK; Lagerveld BW; Keeley F; Lughezzani G; Sriprasad S; Barber NJ; Hansen LU; Buffi NM; Guazzoni G; van der Zee JA; Ismail M; Farrag K; Emara AM; Lund L; Østraat Ø; Borre M
BJU Int; 2017 Mar; 119(3):390-395. PubMed ID: 27488479
[TBL] [Abstract][Full Text] [Related]
19. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
20. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
